Exercise

KKR Real Estate Finance Trust Inc. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Thursday, March 3, 2022
Finance, Banking, Professional Services, Commercial Building & Real Estate, Construction & Property, Private Securities Litigation Reform Act, Form S-3, Forward-looking statement, Risk, Security (finance), U.S. Securities and Exchange Commission, Keefe, Bruyette & Woods, Wells Fargo, 2nd Floor (Nina song), KKR, NYSE, J. P. Morgan, Citigroup, Goldman Sachs, SEC, Sale, Form, Hudson Yards, Varick Street, Attention, 14th Floor Records, Morgan Stanley, Deutsche Bank, KREF, Exercise, Prospectus, Barclays, Property management

KKR Real Estate Finance Trust Inc. (KREF) (NYSE: KREF) today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock.

Key Points: 
  • KKR Real Estate Finance Trust Inc. (KREF) (NYSE: KREF) today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock.
  • The offering is expected to close on March 7, 2022 and is subject to customary closing conditions.
  • KKR Real Estate Finance Trust Inc. (NYSE:KREF) is a real estate finance company that focuses primarily on originating and acquiring senior loans secured by commercial real estate properties.
  • These forward-looking statements include statements relating to, among other things, the proposed issuance and sale of common stock and the expected use of the net proceeds from the offering.

Bowman Announces Full Exercise and Closing of Underwriters’ Overallotment Option in Follow-On Public Offering

Retrieved on: 
Wednesday, March 2, 2022
Professional Services, Other Professional Services, Other Construction & Property, Construction & Property, Building Systems, Consulting, Attention, Forward-looking statement, Isaiah Bowman, Security (finance), U.S. Securities and Exchange Commission, Solution, Telephone, Built environment, Suite, Sale, Form, Bowman, Environment, LLP, Huron Consulting Group, Engineering, Nasdaq, Exercise, Prospectus, Life insurance

After giving effect to the full exercise and close of the overallotment option, the total number of shares sold by Bowman in the follow-on offering increased to 1,057,500 shares and gross proceeds increased to approximately $16.9 million.

Key Points: 
  • After giving effect to the full exercise and close of the overallotment option, the total number of shares sold by Bowman in the follow-on offering increased to 1,057,500 shares and gross proceeds increased to approximately $16.9 million.
  • The exercise of the overallotment option closed on March 2, 2022 and Bowman received additional net proceeds of approximately $2.4 million, after underwriting discounts and commissions.
  • Bowman intends to use the net proceeds from the sale of its shares in the offering for general corporate purposes, investment in organic growth, and the funding of potential acquisitions.
  • Greenberg Traurig, LLP served as legal counsel to Bowman and Akerman LLP served as legal counsel to the underwriters.

Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update

Retrieved on: 
Thursday, March 3, 2022
Health, General Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, NDA, Celgene, Research, Regulation of tobacco by the U.S. Food and Drug Administration, Patient, Investment, RA, Adult, Software, Hair, Investor, Food, Breakthrough therapy, Net international investment position, International, CNCE, FDA, Agitation, New Drug Application, Alopecia areata, Webcast, Severity, Sale, Company, SALT, Medication, Concert, Autoimmune disease, The First Half of My Life, Lists of diseases, Hair loss, Exercise, Otsuka Pharmaceutical, NASDAQ, Music, Pharmaceutical industry, Schizophrenia

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the year ended December 31, 2021.

Key Points: 
  • Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the year ended December 31, 2021.
  • The Company expects to report topline results from the first CTP-543 Phase 3 trial, THRIVE-AA1, in the second quarter of 2022.
  • ET to provide an update on the Company and discuss financial results for the year ended December 31, 2021.
  • A live webcast of the financial results may be accessed in the Investors section of the Companys website at www.concertpharma.com .

North America (NAFTA) Gyms, Health and Fitness Clubs Market Summary, Competitive Analysis and Forecast, 2017-2021 & 2022-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 2, 2022
Fitness & Nutrition, Health, NAFTA, Exercise, North American Free Trade Agreement, Economy of North America, Competitive analysis, Industry, Growth, Compare the Market Australia, Market, CAGR, Health, Oil, Dietary supplement

The "North America (NAFTA) Gyms, Health and Fitness Clubs - Market Summary, Competitive Analysis and Forecast, 2017-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America (NAFTA) Gyms, Health and Fitness Clubs - Market Summary, Competitive Analysis and Forecast, 2017-2026" report has been added to ResearchAndMarkets.com's offering.
  • The NAFTA Gyms, Health & Fitness Clubs industry profile provides top-line qualitative and quantitative summary information including: Market size (value 2017-21, and forecast to 2026).
  • The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the Market.
  • The gyms, health & fitness clubs industry within the NAFTA countries had a total market value of $40.3 billion in 2021.

Nanomix Completes 1-for-173 Reverse Stock Split

Retrieved on: 
Wednesday, March 2, 2022
Health, Medical Devices, Technology, Hospitals, Mobile, Wireless, Software, Biotechnology, CUSIP, Corporation, Industry, Forward-looking statement, Security (finance), Bangladesh Securities and Exchange Commission, Growth, OTCBB, Company, Time, Health, Decision-making, Exercise

Nanomix Corporation (OTCBB: NNMX) (Nanomix or the Company), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced it has completed the previously announced reverse stock split of its outstanding shares of common stock at a ratio of 1-for-173.

Key Points: 
  • Nanomix Corporation (OTCBB: NNMX) (Nanomix or the Company), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced it has completed the previously announced reverse stock split of its outstanding shares of common stock at a ratio of 1-for-173.
  • The reverse stock split was announced on June 29, 2021 in conjunction with the reverse merger with Boston Therapeutics.
  • Based on the number of shares outstanding as of March 1, 2022, the reverse stock split reduced the number of shares of the Companys common stock outstanding from approximately 917 million pre-reverse split to approximately 5.3 million post-reverse split.
  • All outstanding preferred shares, stock options, warrants and equity incentive plans immediately prior to the reverse stock split generally were appropriately adjusted by dividing the number of shares of common stock into which the preferred shares, stock options, warrants and equity incentive plans were exercisable or convertible by 173 and multiplying the exercise or conversion price by 173, as a result of the reverse stock split.

Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest

Retrieved on: 
Wednesday, March 2, 2022
Research, Infectious Diseases, Philanthropy, Biotechnology, Health, General Health, Foundation, Other Science, Science, YouTube, Ageing, Diagnosis, ISB, COVID, Patient, Anxiety, Research, NIH, Prevalence, Common, Risk, Twitter, Infection, University, LinkedIn, Â, Multimedia, Goal, Fatigue, Cancer, COVID-19, Time, Headache, Disease, Cell, The New York Times, Fever, Chronic cough, Institute, Depression, Importance, Health, PASC, Exercise, Severe acute respiratory syndrome coronavirus 2, University of Washington School of Medicine, Incidence, Systems biology, Pharmaceutical industry, Medicine, Points of the compass, Pacific Northwest, Facebook

View the full release here: https://www.businesswire.com/news/home/20220302005352/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220302005352/en/
    Institute for Systems Biology (ISB) is leading a multi-site Pacific Northwest consortium as part of the NIH-funded RECOVER initiative.
  • ISB will work closely with Providence, Swedish, and University of Washington School of Medicine to recruit more than 900 patients throughout the greater Pacific Northwest over four years.
  • The long-term effects of the virus are called post-acute sequelae of SARS-CoV-2 infection, or PASC.
  • Data from the RECOVER study will include clinical information, laboratory tests, and analyses of participants in various stages of recovery following SARS-CoV-2 infection.

Lumen Launches First Metabolic Food Tracker Revealing Impact on Metabolism in Real Time

Retrieved on: 
Wednesday, March 2, 2022
Other Health, Men, Mobile, Wireless, Consumer Electronics, Consumer, Medical Devices, Technology, Fitness & Nutrition, Women, Biotechnology, Other Technology, Health, Google Play, Research, Garmin, Breakfast, Fasting, Sleep, Knowledge, Physiology, Doctor of Philosophy, Ironman, Metabolism, Multimedia, Travel, Lunch, Food, Fats, San Francisco State University, Protein, Technology, Apple Watch, App Store (iOS/iPadOS), Health, Exercise, Feed manufacturing, Medical device, Satellite navigation device, Lumen

Lumen is currently the largest metabolic health platform with over 1 million metabolism measurements made through the device a month.

Key Points: 
  • Lumen is currently the largest metabolic health platform with over 1 million metabolism measurements made through the device a month.
  • Lumen has been peer-reviewed to meet the gold standard for metabolic measurement by a San Francisco State University study .
  • Lumen helps people improve their health and fitness through technology on the forefront of personalized nutrition and metabolism.
  • The Lumen device measures metabolism in a single breath, in less than a minute, which previously was only possible through an hour-long lab test.

Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes

Retrieved on: 
Wednesday, March 2, 2022
General Health, Professional Services, Health, Finance, Risk, Private Securities Litigation Reform Act, SEC Rule 144A, The Act, GlaxoSmithKline, Forward-looking statement, Security (finance), U.S. Securities and Exchange Commission, LLC, Act, Sale, SEC, Company, Time, Securities Act of 1933, TRC, Observation, Fluticasone furoate/umeclidinium bromide/vilanterol, Strategic alliance, Intention, GSK, Exercise, NASDAQ, Pharmaceutical industry, Note

The terms of the Notes, including the interest rate, initial conversion rate and other terms, will be determined upon pricing of the offering.

Key Points: 
  • The terms of the Notes, including the interest rate, initial conversion rate and other terms, will be determined upon pricing of the offering.
  • No assurance can be given as to how much, if any, of the 2023 Notes will be repurchased or the terms on which they will be repurchased.
  • The capped call transactions will cover, subject to customary adjustments, the number of shares of common stock initially underlying the Notes.
  • Trademark reference: Innoviva and the Innoviva logo are registered trademarks or trademarks of Innoviva, Inc. or its affiliates in the United States and/or other countries.

GSR II Meteora Acquisition Corp. Announces the Closing of its $316M Initial Public Offering, Including Fully-Exercised Over-Allotment Option

Retrieved on: 
Tuesday, March 1, 2022
Other Manufacturing, Environment, Technology, Finance, Banking, Professional Services, Software, Manufacturing, Hardware, Electronic Design Automation, GSR, Investment, Nasdaq, Industry, Software, Automation, Forward-looking statement, Security (finance), U.S. Securities and Exchange Commission, Robotics, Telephone, SEC, Company, Sale, Acquisition, Broad Street, Oppenheimer, GSRM, Risk, Partnership, Exercise, Water, Atmosphere, Prospectus

GSR II Meteora Acquisition Corp. (GSRM or the Company) announced today that it closed its initial public offering of 31,625,000 units at a price of $10.00 per unit for aggregate gross proceeds of $316,250,000.

Key Points: 
  • GSR II Meteora Acquisition Corp. (GSRM or the Company) announced today that it closed its initial public offering of 31,625,000 units at a price of $10.00 per unit for aggregate gross proceeds of $316,250,000.
  • GSRM is led by co-CEOs Gus Garcia and Lewis Silberman, President Anantha Ramamurti and CFO Joseph Tonnos.
  • Oppenheimer & Co. Inc. acted as the sole underwriter for the initial public offering.
  • The underwriter has also exercised in full its option to purchase up to an additional 4,125,000 units, at the initial public offering price to cover over-allotments.

Churchill Asset Management Announces 2022 Promotions Following Record-Setting Year

Retrieved on: 
Tuesday, March 1, 2022
Banking, Professional Services, Finance, SIPC, Pitch, Teachers Insurance and Annuity Association of America, CLO, Leadership, Investment, Solution, Pension, LLC, Growth, Winston Churchill, Senior, Association, CEO, TIAA, FINRA, Exercise, Insurance, Judgement, Financial adviser, Nuveen

Churchill Asset Management LLC, an investment-specialist affiliate of Nuveen providing customized financing solutions to private equity firms and their portfolio companies, today announced promotions across the firm following a year of record-setting results.

Key Points: 
  • Churchill Asset Management LLC, an investment-specialist affiliate of Nuveen providing customized financing solutions to private equity firms and their portfolio companies, today announced promotions across the firm following a year of record-setting results.
  • Since joining Churchill in October 2020, Ms. Marti has been responsible for the management and growth of Churchills middle market CLO platform.
  • Also, in 2021, Churchill was selected as one of Pension & Investments Best Places to Work in Money Management.
  • Churchill Asset Management is a registered investment advisor and majority-owned, indirect subsidiary of Teachers Insurance and Annuity Association of America.